The software offer combines lot of the functionalities,
user-friendly and performance.

On the side of reagents, the company is also at the point
of the innovation with the first medium MHR-SIR
allowing a report of the results during the day,
with Inoclic a system of standardization of inoculum,
and finally with a range of antibiotics discs and other
very powerful reagents.

The advance taken on competition allows today
i2a to complete its offer of systems of in vitro expertise,
to design new instruments, software and reagents,
to anticipate the needs for its customers,
the medical research itself, both in France
and in whole Europe, North America ...
... to make future a reality now !

page 2/2